Michelle Noble writes for P3 Pharmacy with guidance for pharmacists considering making alterations to pharmacies
Michelle Noble has written for P3 Pharmacy with guidance for pharmacists considering making alterations to pharmacies. Read more below.
Our thinking
Michael Lingens
Charles Russell Speechlys has advised the owners of The Centre for Reproductive and Genetic Health (CRGH) on its sale to FutureLife
CRGH is the largest private fertility clinic in the London IVF market.
Melania Constable
Melania Constable and Jessica Williams write for Pharmacy Business on what the collapse of Testerworld means for community pharmacies
What does the collapse of Testerworld mean for community pharmacies?
Tertius Alberts
Why are Statutory Registers so important?
The importance of having and maintaining the company’s statutory registers cannot be overlooked.
Anne-Marie Balfour
Protect your connections
In an employment context, employers in the life sciences sector can protect their businesses in a number of ways.
Rebecca Burford
Charles Russell Speechlys acts for Maitland Medical Services Ltd on its acquisition of Soma Health Limited
We have advised Maitland Medical Services Ltd on its acquisition of Soma Health Limited.
Louise Ward
What can UK investors interested in Life Sciences learn from their more experienced, including US, counterparts?
The recent tie-up between Canary Wharf and Kadans demonstrates the enthusiasm to access the lucrative UK life sciences market.
Andrew Collins
Charles Russell Speechlys advises Caretech Holdings PLC on its proposed £870.3 million take private
Charles Russell Speechlys is advising the independent board of Caretech Holdings PLC, in its take private sale to Amalfi Bidco Limited.
Rose Carey
Could the UK’s Life Sciences Vision be restricted by its Immigration Policy?
We explore some of the visa options that may be open to businesses in the sector and their relative pros and cons.
Louise Ward
Louise Ward writes for EG on what UK investors can gain from an overseas life sciences partner
What UK investors can gain from an overseas life sciences partner
Charlotte Healy
Charlotte Healy and Katie Bewick write for Pharmacy Business on expert determination
Charlotte Healy and Katie Bewick write for Pharmacy Business on expert determination
Pei Li Kew
Pei Li Kew writes for Pharmacy Business on the link between pharmacy and IP
Pei Li Kew writes for Pharmacy Business on the link between pharmacy and IP
Louise Ward
Louise Ward quoted by Estates Gazette on the fading support for the Ox-Cam Arc
The government is reported to be rowing back on driving investment to the region, which has been a hotbed of life sciences expertise.
Oliver Park
Oliver Park writes for P3 Pharmacy on the impact of the Building Safety Bill on pharmacy owners
A key requirement under the Order is the need for a fire risk assessment, which must be regularly reviewed.
Jonathan McDonald
Jonathan McDonald and Ilona Bateson write for P3 Pharmacy on data protection compliance for pharmacy business owners
Health organisations hold more sensitive personal health data than ever.
Becky Lawton
Becky Lawton and Francesca Charlton write for P3 Pharmacy on employment issues for pharmacies in light of the Omicron variant
What can owners and managers do if staff refuse to comply with latest restrictions?
Melania Constable
Melania Constable and Georgina O'Sullivan write for P3 Pharmacy on the easing of Covid winding up restrictions
Regulations mean that a creditor can once again rely on an unpaid statutory demand to apply to the court for a winding-up petition.
Jonathan Steele
The Surrey Chambers of Commerce report on the Dental team’s involvement in Dentex’s acquisition of its 100th dental practice
The Dental team in Guildford has advised Dentex on the acquisition of Courtyard Dental Practice based in Saffron Walden in Essex.
Jonathan Steele
Charles Russell Speechlys advises Dentex on the acquisition of Courtyard Dental Practice
Dentex is a fast-growing dental group focussed on developing its practices and optimising how dental practices operate.
Helen Coward
Helen Coward and Cara Whiffin write for Property Week on how the residential property developer tax will affect the retirement living sector
The new residential property developer tax (RPDT) is being introduced from 1 April 2022.
Helen Coward
Residential property developers tax: How might this impact the retirement living sector?
Helen Coward and Cara Fulker explain how residential property developers tax might impact the retirement living sector.